Bruce Hug, MD, PhD

Dr. Bruce Hug has 20 years of clinical development experience from Phase I through Phase III in hematology and oncology working in positions of increasing responsibility. Over the course of his career, Bruce has led early phase immuno-oncology programs covering a range platforms as well as late phase programs leading to successful filings. Most recently, Bruce was a Vice President at Anthos Therapeutics.

Bruce has a BS in Biology from the University of Illinois and MD and PhD degrees from Washington University. He completed residency and fellowship training at the University of Pennsylvania in Clinical Pathology and joined the faculty as an Assistant Professor before moving to pharmaceutical development in 2005.